Home » Topics » Regulatory

Regulatory
RSS

New formulation of enalapril now available in U.K.

Feb. 4, 1998

Zeneca receives patent protection for new Diprivan formulation

Feb. 4, 1998

NexMed completes phase I trial of ED product

Feb. 4, 1998

Crescendo and Alza to collaborate on chronic pain product

Feb. 3, 1998

Topical interferon alfa enters phase II for intravaginal warts

Feb. 2, 1998

Controlled-release oxybutynin to be marketed in Europe by Synthelabo

Feb. 2, 1998

Suramin submitted for FDA approval for cancer indication

Jan. 30, 1998

Proleukin cleared for marketing in U.S. for melanoma indication

Jan. 30, 1998

Anesta signs European marketing agreement for Actiq

Jan. 29, 1998

New once-daily rosacea therapy introduced in U.S.

Jan. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...